Diamond set to sparkle for nanoelectronics


diamond

The new technique can be used to etch smaller structures on diamond than was previously possible © NPG

Scientists in Australia are the first to etch structures less than a hundred nanometres in size on the inclined surfaces of diamond by simply using a variable pressure scanning electron microscope (SEM). They believe their electron beam induced etching (EBIE) could make nanofabrication of diamond devices accessible to every nanotechnology laboratory in the world.

Diamond’s wide optical transparency window and high carrier mobility means that it’s a highly attractive material for optical and optoelectronic structures. But as one of the hardest and most chemically inert materials known, it presents enormous fabrication challenges. Current techniques involving ion bombardment or high power laser ablation that often cause surface damage and create artefacts from the redeposition of non-volatile, sputtered or ablated material.

‘We demonstrate a chemical approach that enables the fabrication of functional diamond structures using gas-mediated electron induced etching,’ explains team leader Igor Aharonovich at the University of Technology, Sydney. Key to their approach was the use of an electron beam in a water vapour environment. This was used to dissociate surface-adsorbed water molecules into radical fragments. The resulting volatile reaction products create voids on the surface when they leave the diamond substrate. By exploiting the high resolution, precise beam steering capabilities of an SEM, they were able to etch sub-100 nm lines on the inclined planes of a single crystal diamond.

Furthermore, spectral analysis revealed that the unique optical properties of diamond remained intact, indicating that no surface damage or redeposition had occurred, unlike standard techniques, which frequently implants gallium ions. ‘The exciting part is that the electron-beam etching avoids implantation of foreign ions,’ explained Christian Degen, whose research in nanometre scale spin detection at ETH Zurich in Switzerland, involves nanostructures made from single crystal diamond. However, given that many applications, such as micron-scale lenses and photonic crystals, take advantage of optically active defects in diamond, Degen would be curious to know what effect electron-beam etching may have.

Among such defects are nitrogen vacancy luminescence centres (NV) employed as spin qubits for next generation quantum devices. ‘EBIE may represent a unique advantage if the authors were able to demonstrate the fabrication of NV-containing diamond solid-immersion lenses without any risk of quenching the NV centre,’ agreed Ye Tao, a member of Degen’s lab.

For the moment, however, Aharonovich and his colleagues are continuing to investigate the universal appeal of EBIE as a technique for other wide band gap semiconductors. ‘EBIE can be applied to any system where a volatile reaction product can be formed by a dissociated precursor radical and target substrate material,’ he says.


Related Content

Diamonds are for everything

30 August 2011 Feature

news image

No longer valued simply for its glamour and durability, diamond is turning its hand to applications in solar power, laser des...

Crystal clear

13 December 2013 Premium contentFeature

news image

With the international year of crystallography upon us, Clare Sansom celebrates this important discipline

Most Read

UC Davis chemist sentenced to four years over explosion

19 November 2014 News and Analysis

news image

Postdoc sentenced over attempt to make explosive device and reckless disposal of hazardous waste

Spanish fly

10 October 2013 Podcast | Compounds

news image

Helen Scales looks at cantharidin, the active ingredient in this famous aphrodisiac

Most Commented

Beetle behind breath test for bank notes

17 November 2014 Research

news image

Photonic crystal inks inspired by longhorn beetle could help to fight counterfeiting

Bayer wins race to buy Merck & Co consumer care

9 May 2014 Business

news image

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company